风湿科远程医疗:COVID-19期间视频随访的高敏感性与特异性
该研究评估视频远程访视在炎症性风湿病(IRDs)紧密控制策略中识别需调整治疗患者的可靠性。106例RA、PsA、AS或SLE患者先接受视频咨询,2周内重复面对面评估;结果显示视频访视对识别因疾病控制不佳需调整治疗的敏感性94.1%、特异性96.7%,但识别需减量治疗的敏感性仅55.6%,SLE诊断是主要驱动因素。
要点
- 视频访视识别因疾病控制不佳需调整治疗的敏感性和特异性均高。
- SLE患者视频识别需减量治疗的敏感性低,主要因糖皮质激素减量不一致。
- 远程评估的患者报告结局(PROs)可靠性高,疾病活动度指标一致性不一。
核心结论
- 视频访视在识别需调整治疗方面具有高可靠性,可能支持IRDs标准紧密控制策略。
研究设计与样本
- 紧密随访的成人RA、PsA、AS或SLE患者在COVID-19封锁期间接受视频咨询,并在2周内重复面对面风湿科评估,以面对面访视为参考方法计算敏感性和特异性及ICC。
主要发现
- 106例患者中89例(84.0%)面对面访视确认了远程治疗决策。
- 视频访视识别因疾病控制不佳需调整治疗的敏感性为94.1%(95% CI: 71.3%, 99.9%),特异性为96.7%(95% CI: 90.8%, 99.3%)。
- 视频访视识别需减量治疗的敏感性为55.6%(95% CI: 21.2%, 86.3%),SLE诊断是主要驱动因素(OR 10.0; 95% CI: 3.1, 32.3; P <0.001),多因与面对面访视在糖皮质激素减量上不一致。
- 远程评估的PROs可靠性高(ICC范围0.80-0.95),疾病活动度指标数据一致性较低(ICC范围0.50-0.95),尤其在需更广泛体格检查的SLE和PsA中。
关键数值与推荐
- 视频访视识别需调整治疗的敏感性94.1%(95% CI: 71.3%, 99.9%),特异性96.7%(95% CI: 90.8%, 99.3%)。
- 视频访视识别需减量治疗的敏感性55.6%(95% CI: 21.2%, 86.3%)。
- SLE诊断与识别减量治疗低敏感性的OR为10.0(95% CI: 3.1, 32.3; P <0.001)。
- 远程PROs的ICC范围为0.80-0.95,疾病活动度指标的ICC范围为0.50-0.95。
临床怎么用
- 视频访视可用于IRDs紧密控制策略中识别需调整治疗的患者。
- 对SLE患者通过视频评估减量治疗需谨慎,尤其涉及糖皮质激素减量时。
局限性
- 疾病活动度指标远程评估一致性较低,尤其SLE和PsA等需广泛体格检查的疾病。
- 识别需减量治疗的敏感性低,SLE为主要驱动因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the reliability of virtual video-assisted visits, added to the tight-control strategy for inflammatory rheumatic diseases (IRDs), in identifying patients who need treatment adjustment. METHODS: Tightly followed-up adult patients with RA, PsA, AS or SLE took part in a video consultation during COVID19 lockdown and repeated the same rheumatology evaluations through a face-to-face visit within 2 weeks. The sensitivity and specificity of the virtual visits for treatment decisions (categorized as: unchanged, adjusted/escalated, tapered/discontinued, need for further examinations), and the intraclass correlation coefficient (ICC) for virtually measured disease activity and patient-reported outcomes (PROs) were calculated with 95% CIs using face-to-face visits as the reference method. RESULTS: In 89 out of 106 patients (84.0%), face-to-face visits confirmed the remotely delivered treatment decision. Video-visiting showed excellent sensitivity (94.1% with 95% CI: 71.3%, 99.9%) and specificity (96.7%; 95% CI: 90.8%, 99.3%) in identifying the need for treatment adjustment due to inadequate disease control. The major driver for the low sensitivity of virtual video consultation (55.6%; 95% CI: 21.2%, 86.3%) in identifying the need for treatment tapering was SLE diagnosis [odds ratio (OR) 10.0; 95% CI: 3.1, 32.3; P <0.001], mostly because of discordance with face-to-face consultation in glucocorticoid tapering. Remotely evaluated PROs showed high reliability (ICC range 0.80-0.95), while disease activity measures had less consistent data (ICC range 0.50-0.95), especially for those diseases requiring more extensive physical examination, such as in SLE and PsA. CONCLUSION: Video-visiting proved to have high reliability in identifying the need for treatment adjustment and might support the IRDs standard tight-control strategy.
引用
- Piga M, Floris A, Congia M, et al. Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic. Rheumatology (Oxford). 2022. PMID: 34352098. doi:10.1093/rheumatology/keab632
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。